Paratek To Acquire Optinose, Expanding Portfolio Beyond Antibiotics

 
• By Joseph Haas
  
merger and acquisition business concepts, join company on puzzle pieces, 3d rendering
Paratek will acquire Optinose and CRS drug Xhance
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Therapy Areas